Judith G Villablanca

Judith G Villablanca

UNVERIFIED PROFILE

Are you Judith G Villablanca?   Register this Author

Register author
Judith G Villablanca

Judith G Villablanca

Publications by authors named "Judith G Villablanca"

Are you Judith G Villablanca?   Register this Author

38Publications

1172Reads

39Profile Views

Revisions to the International Neuroblastoma Response Criteria: A Consensus Statement From the National Cancer Institute Clinical Trials Planning Meeting.

J Clin Oncol 2017 Aug 4;35(22):2580-2587. Epub 2017 May 4.

Julie R. Park, Seattle Children's Hospital and University of Washington School of Medicine, Seattle, WA; Rochelle Bagatell and John M. Maris, Children's Hospital of Philadelphia and University of Pennsylvania School of Medicine, Philadelphia, PA; Susan L. Cohn, University of Chicago, Chicago, IL; Andrew D. Pearson, Institute of Cancer Research and Royal Marsden National Health Service (NHS) Foundation Trust, Sutton, Surrey; Susan Burchill, Leeds Institute of Cancer and Pathology, St James University Hospital, Leeds; Kieran McHugh and Penelope Brock, Great Ormond Street Hospital for Children, NHS Trust, London, United Kingdom; Judith G. Villablanca, Children's Hospital Los Angeles and University of Southern California Keck School of Medicine, Los Angeles; Katherine K. Matthay, University of California San Francisco School of Medicine, San Francisco, CA; Frank Berthold, Children's Hospital and University of Cologne, Köln, Germany; Ariane Boubaker, Institute of Radiology, Clinique de La Source, Lausanne, Switzerland; Jed G. Nuchtern, Texas Children's Hospital and Baylor College of Medicine, Houston, TX; Wendy B. London, Dana-Farber/Boston Children's Cancer and Blood Disorder Center, Harvard Medical School, Boston, MA; Nita L. Seibel and O. Wolf Lindwasser, National Cancer Institute, Bethesda, MD; Gudrun Schleiermacher, Institut Curie, Paris; Dominique Valteau-Couanet, Gustave Roussy, Villejuif, France; and Ruth Ladenstein, Children's Cancer Research Institute, St Anna Children's Hospital, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.72.0177DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5676955PMC
August 2017

Different outcomes for relapsed versus refractory neuroblastoma after therapy with (131)I-metaiodobenzylguanidine ((131)I-MIBG).

Eur J Cancer 2015 Nov 5;51(16):2465-72. Epub 2015 Aug 5.

Department of Pediatrics, University of California San Francisco School of Medicine and UCSF Benioff Children's Hospital, San Francisco, CA, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2015.07.023DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4607645PMC
November 2015

Pilot study of intravenous melphalan combined with continuous infusion L-S,R-buthionine sulfoximine for children with recurrent neuroblastoma.

Pediatr Blood Cancer 2015 Oct 7;62(10):1739-46. Epub 2015 Jul 7.

Cancer Center and Departments of Cell Biology & Biochemistry, Pediatrics and Medicine, School of Medicine, Texas Tech University Health Sciences Center, Lubbock, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.25594DOI Listing
October 2015

Probable fatal drug interaction between intravenous fenretinide, ceftriaxone, and acetaminophen: a case report from a New Approaches to Neuroblastoma (NANT) Phase I study.

BMC Res Notes 2014 Apr 23;7:256. Epub 2014 Apr 23.

Cancer Center and Departments of Cell Biology and Biochemistry, Pharmacology and Neuroscience, Pediatrics, and Internal Medicine, School of Medicine, Texas Tech University Health Sciences Center, 3601 4th Street, STOP 9445 79430 Lubbock, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1756-0500-7-256DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4006848PMC
April 2014

Phase I trial of fenretinide delivered orally in a novel organized lipid complex in patients with relapsed/refractory neuroblastoma: a report from the New Approaches to Neuroblastoma Therapy (NANT) consortium.

Pediatr Blood Cancer 2013 Nov 29;60(11):1801-8. Epub 2013 Jun 29.

Department of Cell Biology & Biochemistry, Texas Tech University Health Sciences Center, Lubbock, Texas; Department of Pediatrics, Texas Tech University Health Sciences Center, Lubbock, Texas; Department of Medicine, Texas Tech University Health Sciences Center, Lubbock, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.24643DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4066886PMC
November 2013

The significance of serial histopathology in a residual mass for outcome of intermediate risk stage 3 neuroblastoma.

Pediatr Blood Cancer 2012 May;58(5):675-81

Department of Pediatrics, Children's Hospital Los Angeles, USC Keck School of Medicine, Los Angeles, California, USA.

View Article

Download full-text PDF

Source
May 2012

Phase I trial of lestaurtinib for children with refractory neuroblastoma: a new approaches to neuroblastoma therapy consortium study.

Cancer Chemother Pharmacol 2011 Oct 22;68(4):1057-65. Epub 2011 Feb 22.

Department of Pediatrics and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, University of Pennsylvania, Philadelphia, PA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-011-1581-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4238911PMC
October 2011

Phase I trial of oral fenretinide in children with high-risk solid tumors: a report from the Children's Oncology Group (CCG 09709).

J Clin Oncol 2006 Jul;24(21):3423-30

Children's Hospital Los Angeles and the Department Pediatrics, University of Southern California Keck School of Medicine, Los Angeles, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2005.03.9271DOI Listing
July 2006

A Phase I study of concurrent RMP-7 and carboplatin with radiation therapy for children with newly diagnosed brainstem gliomas.

Cancer 2005 Nov;104(9):1968-74

Center for Neuroscience and Behavioral Medicine, Division of Neurology, Children's National Medical Center, Washington, DC 20010, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/cncr.21403
Publisher Site
http://dx.doi.org/10.1002/cncr.21403DOI Listing
November 2005

Approaches to treatment for extraocular retinoblastoma: Children's Hospital Los Angeles experience.

J Pediatr Hematol Oncol 2004 Jan;26(1):31-4

Department of Pediatrics, University of Southern California Keck School of Medicine and Children's Hospital Los Angeles, Los Angeles California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/00043426-200401000-00011DOI Listing
January 2004

Retinoid therapy of high-risk neuroblastoma.

Cancer Lett 2003 Jul;197(1-2):185-92

Division of Hematology-Oncology, Children's Hospital of Los Angeles and The University of Southern California Keck School of Medicine, Los Angeles, CA 90054, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0304-3835(03)00108-3DOI Listing
July 2003

Successful multimodality therapy of recurrent multifocal juvenile granulosa cell tumor of the ovary.

J Pediatr Hematol Oncol 2002 Mar-Apr;24(3):229-33

Department of Pediatrics, Childrens Hospital Los Angeles, Keck School of Medicine, California 90027, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/00043426-200203000-00015DOI Listing
May 2002